Richard S. Creager

LifeScience Alley provides access to industry leaders, opportunities to build business through education and networking, insights into current trends, regulations, research and emerging technologies. The private company is based in St. Louis Park, MN. Shaye R. Mandle has been the CEO of the company since 2011.

Ubiquitome Ltd. engages in development and provision of cloud solutions for clinical, environmental, conservation, and forensic applications. The company was founded by Paul Pickering and is headquartered in Auckland, New Zealand.

Onramp Bioinformatics, Inc. develops bioinformatics solutions for genomics analysis. Its software solutions provide computational analysis and storage services for pharmaceuticals, clinicians, researchers, sequence service providers, and biotechnology professionals. The company was founded by Tim Wesselman in 2013 and is headquartered in San Diego, CA.

Seraph Biosciences, Inc. develops Raman Spectroscopy that operates as a equipment for real-time pathogen detection and point of care. The company was founded by Charles Shanley, Gregor Auner, and Mark Trexler and is headquartered in Detroit, MI.

ProteoGenix is the first and only company solely committed to developing minimally invasive diagnostics that address unmet medical needs and improve pregnancy and neonatal management and outcomes. By applying innovative proteomic and molecular technologies, ProteoGenix has quickly become a leader in developing powerful diagnostic tools that have the potential to dramatically change the future of pregnancy and neonatal management. In 2002, four leading researchers in the area of perinatology and neonatology joined together to create ProteoGenix, a company dedicated to solving the mysteries of preterm birth and the significant medical, emotional and economic consequences that prematurity has on their society. Their passion for improving pregnancy management and the outcomes associated with preterm birth, along with their clinical expertise and scientific acumen, led ProteoGenix to achieve a truly significant recent scientific discovery identification of The Proteomic Map of Pregnancy. The physicians and scientists that became ProteoGenix were the first to identify and characterize a fundamental map of the key biologic fluids in pregnancy and show how this landscape changes in important pregnancy-related disorders. This groundbreaking work has received several significant scientific awards, including Best Clinical Study at the 2007 annual meeting of the Society for Maternal-Fetal Medicine, and has been the topic of numerous peer-reviewed publications. ProteoGenix has also developed the unique capability to utilize sophisticated nucleic acid-based molecular microbiology techniques such as quantitative Polymerase Chain Reaction (PCR) and Pyrosequencing, specifically optimized for use in key maternal, fetal, neonatal biological fluids to detect infectious and path physiological diseases associated with pregnancy.

Beckman Coulter, Inc. manufactures and distributes biomedical testing instrument systems and general biomedical research products. It develops and markets products that simplify, automate and innovate complex biomedical testing. The firm’s systems operate in both diagnostics and life sciences laboratories on seven continents. Its products improve the productivity of medical professionals and scientists, supplying critical information for improving patient health and delivering trusted solutions for research and discovery. The company was founded in 1935 by Arnold O. Beckman and is headquartered in Brea, CA.